News for TAPIMMUNE INC (TPIV)

News for TAPIMMUNE INC
Date Headline
Feb 15, 2017 09:15 AM TapImmune Advances TPIV 200 Phase 2 Triple-Negative Breast Cancer Trial After Favorable DSMB Safety Review
Feb 09, 2017 08:30 AM TapImmune, Inc. Presentation Now Available for On-Demand Viewing
Feb 09, 2017 08:30 AM TapImmune, Inc. Presentation Now Available for On-Demand Viewing
Feb 07, 2017 09:15 AM TapImmune Expands Intellectual Property On PolyStartâ„¢ Platform For Use In Next-Generation T-Cell Vaccines
Feb 02, 2017 09:15 AM TapImmune Completes Scale-Up and GMP Manufacturing of TPIV 200 Vaccine to Supply Additional Phase 2 Clinical Trials
Jan 30, 2017 02:16 PM Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd
Jan 30, 2017 02:16 PM Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd
Jan 30, 2017 08:30 AM TapImmune, Inc. to Webcast, Live, at VirtualInvestorConferences.com February 2
Jan 30, 2017 08:30 AM TapImmune, Inc. to Webcast, Live, at VirtualInvestorConferences.com February 2
Jan 24, 2017 09:15 AM TapImmune Announces Progress In Its Phase 2 Ovarian Cancer Clinical Trial